What is Clindamycin topical?
Category: Prescription Drugs
Most popular types: Dalacin T Cleocin T Clindesse
Clindamycin topical is an antibiotic skin product that is used topically for skin conditions, such as the treatment of severe acne.
| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Acne | 116 | 13 | |
| Hidradenitis suppurativa | 68 | 2 | |
| Acne breakout | 8 | 2 | |
| Folliculitis | 3 | 4 | |
| Scalp lesions | 2 | 0 |
- Major
- Moderate
- Slight
- None
- Can't tell
Side effects
Side effects as an overall problem
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 0 | |
| Moderate | 1 | |
| Mild | 5 | |
| None | 14 |
Commonly reported side effects and conditions associated with Clindamycin topical
| Side effect | Patients | Percentage |
|---|---|---|
| Dry skin | 4 | |
| Dryness | 1 | |
| Dry peeling facial skin | 1 | |
| Rosacea | 1 | |
| Skin peeling | 1 | |
| Stinging sensation | 1 |
Why patients stopped taking Clindamycin topical
Multiple reasons could be selected
| Reason | Patients | Percentage |
|---|---|---|
| Other | 13 | |
| Did not seem to work | 8 | |
| Course of treatment ended | 4 | |
| Change in health plan coverage | 3 | |
| Side effects too severe | 2 | |
| Doctor's advice | 1 |
Duration
Stopped taking Clindamycin topical
| Duration | Patients | Percentage |
|---|---|---|
| Less than 1 month | 3 | |
| 1 - 6 months | 3 | |
| 6 months - 1 year | 8 | |
| 1 - 2 years | 5 | |
| 2 - 5 years | 4 | |
| 5 - 10 years | 1 | |
| 10 years or more | 1 |
What people switch to and from
Patients started taking Clindamycin topical after stopping:
| Treatment | Patients | Percentage |
|---|---|---|
| Metronidazole topical (MetroGel) | 1 | |
| Tazarotene (Tazorac) | 1 |
Patients stopped taking Clindamycin topical and switched to:
| Treatment | Patients | Percentage |
|---|---|---|
| Adalimumab (Humira) | 1 | |
| Dapsone (DDS) (Aczone) | 1 | |
| Etanercept (Enbrel) | 1 | |
| Isotretinoin (Accutane) | 1 | |
| Tretinoin-Clindamycin topical (Ziana) | 1 |
Last updated: